CO2 vs Air Insufflation in Children Undergoing PEG
NCT04714021 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2021-01-19
Summary
Ap¬plications of CO2 insufflation for endoscopic procedures have been reported for the performance of routine colonoscopy, small bowel endoscopy, endoscopic retro¬grade cholangiopancreatography (ERCP) and endoscopic submucosal dissection in the upper and lower gastrointestinal tracts. These studies showed that CO2 insufflation reduces the post-procedural abdominal distension and pain without CO2 retention and adverse events. However, there has been no report on the safety and efficacy of CO2 insufflation in PEG procedures in adults or in children. In the present study, we would like to evaluate by randomized controlled trial: the safety of the CO2 insufflation during PEG and the inhibi¬tory effects of CO2 insufflation on bowel distension after PEG.
Conditions
- Gastrostomy
Interventions
- OTHER
-
CO2
to insufflate CO2 into the stomach instead of air during the PEG
- OTHER
-
air
to insufflate air into the stomach instead of CO2 during the PEG
Sponsors & Collaborators
-
European Society of Pediatric Gastroenterology, Hepatology and Nutrition
collaborator OTHER -
University Medical Centre Ljubljana
lead OTHER
Principal Investigators
-
Matjaz Homan, PhD · Children's Hospital in Ljubljana
-
Mike Thomson, PhD · Sheffield Children's Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Max Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-01-07
- Primary Completion
- 2023-01-07
- Completion
- 2023-01-07
Countries
- Belgium
- Croatia
- Italy
- Slovenia
- Switzerland
- United Arab Emirates
- United Kingdom
Study Locations
More Related Trials
-
Outcome Study of Endoscopically Inserted Gastrostomy (PEG)Versus Radiologically-guided Insertion of Gastrostomy (RIG)in Children
NCT01920438 ·Status: UNKNOWN ·Phase: NA
-
Neuromuscular Blockade Reversal Agent Effect on Postoperative Cognitive Function and Behaviour in Children
NCT02455921 ·Status: COMPLETED ·Phase: PHASE4
-
A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome
NCT05535361 ·Status: RECRUITING ·Phase: NA
-
Acceptability and Tolerance Study of Bolus Tube Feed With Food Blends
NCT07341464 ·Status: RECRUITING ·Phase: NA
-
Comparison of the Therapeutic Effect of Acupressure Therapy and Iberogast ® (STW-5) in Children With Functional Nausea
NCT02660970 ·Status: COMPLETED ·Phase: NA
-
Pilot Study to Investigate the Effect of Teduglutide on Temporary Ileostomy Function and Complications
NCT03953170 ·Status: WITHDRAWN ·Phase: PHASE3
-
Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition
NCT02682381 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
NCT01571297 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of IAM With an I-gel® on Ventilation Parameters in Simulated Pediatric OHCA
NCT05498402 ·Status: COMPLETED ·Phase: NA
-
Evaluation of 70% Ethanol Lock Solution to Prevent Catheter Related Blood Stream Infections in Pediatric Patients
NCT01409772 ·Status: WITHDRAWN
-
Impact of 2 Resuscitation Sequences on Management of Simulated Pediatric Cardiac Arrest
NCT05474170 ·Status: COMPLETED ·Phase: NA
-
Multi-Channel Gastric Electrical Stimulation for the Treatment of Gastroparesis
NCT00595621 ·Status: COMPLETED ·Phase: NA
-
Safety During Use of Paediatric Triple Chamber Bag Formulas
NCT01304394 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants With Symptomatic Diabetic or Idiopathic Gastroparesis
NCT04303195 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome
NCT00081458 ·Status: COMPLETED ·Phase: PHASE3
-
Quality of Life in Patients With Short Bowel Syndrome Treated Without and With Teduglutide - a Prospective Nested Matched Pair Analysis
NCT04733066 ·Status: UNKNOWN
-
Safety, Efficacy and Pharmacokinetic Study of Teduglutide in Infants 4 to 12 Months of Age With Short Bowel Syndrome
NCT03571516 ·Status: COMPLETED ·Phase: PHASE3
-
LASER THERAPY IN GASTRIC STOMA INJURIES OF CHILDREN AND ADOLESCENTS
NCT04863196 ·Status: UNKNOWN ·Phase: NA
-
Comparing Reversal With Neostigmine and Sugammadex in Paediatric
NCT03137290 ·Status: COMPLETED ·Phase: NA
-
Dornase Alfa and Urokinase for Kids With Pleural Empyema
NCT00502632 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Nitrous Oxide for Analgesia During Nasogastric Tube Placement in Young Children
NCT04008628 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic Gastroparesis
NCT00612014 ·Status: COMPLETED ·Phase: PHASE2
-
Sugammadex vs Neostigmine Reversal in Pediatric Appendectomy
NCT05256901 ·Status: TERMINATED ·Phase: PHASE4
-
Temporary Gastric Electrical Stimulation for Gastroparesis
NCT01054794 ·Status: COMPLETED ·Phase: NA
-
Feasibility of Aerodigestive Stimulation Therapy Trial
NCT06118697 ·Status: RECRUITING ·Phase: NA